MRSA drug gains approval through govt's rapid process ... Kindred blasts Gentiva over 'poison pill' ... Improved vision increases seniors' fall risk? ... Observation stays for falls increase in WA
Omnicare announced Monday that it is extending its offer to purchase all outstanding shares of rival PharMerica for $15 per share to Jan. 20. The original offer was scheduled to expire Dec. 2.